ZA200711048B - Tablet containing hardly soluble active incredient - Google Patents

Tablet containing hardly soluble active incredient

Info

Publication number
ZA200711048B
ZA200711048B ZA200711048A ZA200711048A ZA200711048B ZA 200711048 B ZA200711048 B ZA 200711048B ZA 200711048 A ZA200711048 A ZA 200711048A ZA 200711048 A ZA200711048 A ZA 200711048A ZA 200711048 B ZA200711048 B ZA 200711048B
Authority
ZA
South Africa
Prior art keywords
hardly soluble
tablet containing
soluble active
containing hardly
incredient
Prior art date
Application number
ZA200711048A
Other languages
English (en)
Inventor
Marunaka Shigeyuki
Fukuta Makoto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37570471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200711048(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ZA200711048B publication Critical patent/ZA200711048B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200711048A 2005-06-22 2006-06-21 Tablet containing hardly soluble active incredient ZA200711048B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005182415 2005-06-22

Publications (1)

Publication Number Publication Date
ZA200711048B true ZA200711048B (en) 2009-05-27

Family

ID=37570471

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200711048A ZA200711048B (en) 2005-06-22 2006-06-21 Tablet containing hardly soluble active incredient

Country Status (18)

Country Link
US (1) US8821926B2 (xx)
EP (1) EP1900368B1 (xx)
JP (1) JP5220408B2 (xx)
KR (1) KR20080027783A (xx)
CN (1) CN101247805B (xx)
AU (1) AU2006260201B2 (xx)
BR (1) BRPI0611618A2 (xx)
CA (1) CA2612090C (xx)
CR (1) CR9632A (xx)
ES (1) ES2366381T3 (xx)
HK (1) HK1115315A1 (xx)
IL (1) IL187916A (xx)
MX (1) MX2007015783A (xx)
NO (1) NO20080248L (xx)
NZ (1) NZ564407A (xx)
RU (1) RU2420278C2 (xx)
WO (2) WO2006137443A1 (xx)
ZA (1) ZA200711048B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018569A1 (fr) * 2006-08-10 2008-02-14 Takeda Pharmaceutical Company Limited Composition pharmaceutique
WO2009084023A2 (en) * 2007-10-19 2009-07-09 Glenmark Generics Limited Amorphous ramelteon and process for the preparation thereof
AU2010206224B2 (en) * 2009-01-21 2012-12-13 F. Hoffmann-La Roche Ag Pharmaceutical compositions comprising a HCV polymerase inhibitor prodrug
TWI438200B (zh) * 2009-02-17 2014-05-21 必治妥美雅史谷比公司 Ｃ型肝炎病毒抑制劑
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
CN103989643B (zh) * 2013-07-26 2018-10-30 武汉先路医药科技有限公司 含有雷美替胺和共聚维酮的片剂
CN104546746A (zh) * 2013-10-28 2015-04-29 南京长澳医药科技有限公司 一种雷美替胺片剂及其制备工艺
KR20190008265A (ko) 2016-05-06 2019-01-23 피지션즈 씰, 엘엘씨 발레리안 조성물 및 관련 방법
JP7407364B2 (ja) * 2019-02-12 2024-01-04 日本ジェネリック株式会社 ラメルテオン含有固形製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
CA2241666C (en) * 1996-03-08 2007-11-06 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
JPH11322584A (ja) 1998-05-07 1999-11-24 Sawai Pharmaceutical Co Ltd ベザフィブラート徐放性製剤
DE69910795T2 (de) * 1998-06-09 2004-06-17 Takeda Chemical Industries, Ltd. Pharmazeutische kombination mit einer trizyclischen verbindung und mindestens einer von zolpidem, zopiclone und brotizolam, zur behandlung oder verhinderung von schlafstörungen
CN1227001C (zh) * 1999-09-10 2005-11-16 兰贝克赛实验室有限公司 依托度酸的缓释制剂
DE60142305D1 (de) * 2000-11-17 2010-07-15 Takeda Pharmaceutical Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
JP4848558B2 (ja) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
JP4754211B2 (ja) 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法

Also Published As

Publication number Publication date
HK1115315A1 (en) 2008-11-28
WO2006137443A1 (ja) 2006-12-28
US8821926B2 (en) 2014-09-02
RU2008102238A (ru) 2009-07-27
BRPI0611618A2 (pt) 2011-05-31
KR20080027783A (ko) 2008-03-28
EP1900368A4 (en) 2009-08-12
AU2006260201A1 (en) 2006-12-28
AU2006260201B2 (en) 2011-10-20
JPWO2006137443A1 (ja) 2009-01-22
CN101247805B (zh) 2012-10-10
JP5220408B2 (ja) 2013-06-26
CA2612090C (en) 2014-06-10
RU2420278C2 (ru) 2011-06-10
EP1900368B1 (en) 2011-05-11
NZ564407A (en) 2011-03-31
IL187916A0 (en) 2008-03-20
CR9632A (es) 2008-02-04
CN101247805A (zh) 2008-08-20
IL187916A (en) 2013-11-28
EP1900368A1 (en) 2008-03-19
US20090036522A1 (en) 2009-02-05
CA2612090A1 (en) 2006-12-28
ES2366381T3 (es) 2011-10-19
MX2007015783A (es) 2008-02-21
NO20080248L (no) 2008-01-14
WO2007004425A1 (ja) 2007-01-11

Similar Documents

Publication Publication Date Title
PL1876897T3 (pl) Kombinacje substancji czynnych
EP1948543A4 (en) DISPENSER OF TABLETS
HK1120726A1 (en) Stable tablet containing droxidopa
PL1893024T3 (pl) Kombinacje substancji aktywnych
ZA200710548B (en) Active substance combinations
EP1905430A4 (en) TABLET
EP1885583A4 (en) ACTIVE UPHOLSTERY
ZA200711048B (en) Tablet containing hardly soluble active incredient
EP1943700A4 (en) ACTIVE ANTENNA
PT1850664E (pt) Formulação de cápsulas
GB2414462B (en) Active container
GB0500643D0 (en) Medicaments
GB0513984D0 (en) Dosage form
GB0424323D0 (en) Tablet
ZA200904654B (en) Tablet formulation
GB0511204D0 (en) Medicaments
EP1915988A4 (en) COMPRESSOR COMPRISING MULTIPLE SEGMENTS CONTAINING MEDICAMENTS
TWM299332U (en) Active alarm
EP1867324A4 (en) COMPRESSED
IL177755A0 (en) Capsule container
EP1853258A4 (en) DRUGS
TWI372053B (en) Combination drug
GB2423975B (en) Capsules
EP1844770A4 (en) ORNITHINHYDROCHLORIDE-CONTAINING TABLETS
PL376281A1 (pl) Aktywny znak drogowy